Back

Telomerase Prevents Emphysema in Old Mice by Sustaining Subpopulations of Endothelial and AT2 Cells

BREAU, M.; CAYROU, C.; CHURIKOV, D.; FOUILLADE, C.; CURRAS ALONSO, S.; BAUWENS, S.; JOURQUIN, F.; BRAUD, L.; FIORE, F.; CATELLANO, R.; JOSSELIN, E.; SANCHEZ-FERRER, C.; GIOVINAZZO, G.; GILSON, E.; FLORES, I.; LONDONO-VALLEJO, A.; ADNOT, S.; GELI, V.

2021-01-08 molecular biology
10.1101/2021.01.07.425708 bioRxiv
Show abstract

Accumulation of senescent cells has been causally linked to the development of age-related pathologies. Here, we characterized a new mouse model (p21+/Tert) whose telomerase (TERT) is expressed from the p21 promoter that can be activated in response to telomere dysfunction. Lung parenchyma from p21+/Tert old mice accumulated fewer senescent cells with age and this correlated with a reduction in age-related alveolar space enlargement, a feature of pulmonary emphysema. This protection against emphysema depends on TERT catalytic activity and is associated with increased proliferation of pulmonary endothelial cells (EC) and capillary density. Single-cell RNA sequencing of lung cells revealed that TERT expression was associated with the enrichment of ECs expressing genes involved in vessel regeneration and in AT2 cells overexpressing S/G2M markers. These findings indicate that p21-promoter-dependent expression of catalytically active telomerase prevents emphysema by sustaining the proliferation of subclasses of EC and AT2 cells.

Matching journals

The top 3 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.